Subsequent Event (Details) - Kissei Pharmaceutical Co., Ltd. - Subsequent events $ in Millions |
1 Months Ended |
|---|---|
|
Oct. 31, 2018
USD ($)
| |
| Subsequent Event [Line Items] | |
| Upfront payment received | $ 33 |
| Contingent payments | $ 147 |
| X | ||||||||||
- Definition Represents the amount of upfront fees received during the period under the terms of collaborative and licensing agreement. No definition available.
|
| X | ||||||||||
- Definition Represents additional contingent payments by entities. No definition available.
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|